Puneeth Iyengar, MD, PhD

Memorial Sloan Kettering Cancer Center
New York, NY

Puneeth Iyengar is an Associate Professor and Chief of Thoracic Radiation Oncology at UT Southwestern Medical Center. He is also Associate Vice Chair for Research for the Department of Radiation Oncology and Co Leader of the Thoracic Program at UTSW.  He has led programs investigating the use of local therapy (SBRT) in the setting of oligometastatic NSCLC (Iyengar et al, JCO 2014, Iyengar et al JAMA Oncology 2017), hypofractionated therapies for stage III NSCLC,  and is principal investigator of NRG LU 002, a phase III randomized trial assessing the benefits of local therapy on overall survival for stage IV NSCLC.  Dr. Iyengar also runs an independent research laboratory studying cancer cachexia from a basic science and translational perspective. Dr. Iyengar trained at MD Anderson Cancer Center and received his MD, PhD degrees at Albert Einstein College of Medicine (NYC) and Bachelor of Science at MIT.

Disclosures:

• Employment: MSKCC:Attending and Director:Employee
• Compensation: AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: N/A ;Incyte: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: N/A
• Ownership: none
• Leadership: none

Presentation(s):

• LBA13 - Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs)

  Tuesday, October 1, 2024
  3:20 PM – 3:30 PM ET